Skip to main content

$0.160 -0.005 (-3.03%)

High

$0.16

Low

$0.16

Trades

13

Turnover

$11,013

Volume

68,980
30 June 2023 at 12:18pm
Register to track KZA and receive email alerts.
Subject
KZA Ann: Kazia receives Nasdaq minimum bid notice

KZA Ann: EVT801 preclinical data published

KZA Ann: Kazia AGM results

KZA Ann: AGM materials

KZA Ann: Change in substantial holding

KZA Ann: Kazia presents to Bell Potter Healthcare Conference

KZA Ann: Kazia to present to SNO

KZA Ann: Change in substantial holding

KZA Ann: Cleansing notice

KZA Ann: Application for quotation of securities - KZA

KZA Ann: Withdrawal of resolution

KZA Ann: Change in substantial holding

KZA Ann: Quarterly Activities/Appendix 4C Cash Flow Report

KZA Ann: Change in substantial holding

KZA Ann: Positive melanoma data for Kazia's paxalisib

KZA Ann: Kazia SEC Form 20F

KZA Ann: Notice of Annual General Meeting/Proxy Form

KZA Ann: Cleansing notice

KZA Ann: Application for quotation of securities - KZA

KZA Ann: Expansion of PNOC study into Australia

KZA Ann: Kazia AGM date

KZA Ann: Cleansing notice

KZA Ann: Application for quotation of securities - KZA

KZA Ann: Cleansing notice

KZA Ann: Application for quotation of securities - KZA

KZA Ann: Kazia presentation to HCW Bioconnect

KZA Ann: Kazia to present at ESMO

KZA Ann: Change in Directors interests

KZA Ann: Ceasing to be a substantial holder

KZA Ann: Kazia Annual Report to shareholders

KZA Ann: Kazia Appendix 4E

KZA Ann: Kazia Appendix 4G

KZA Ann: Kazia Corporate Governance Statement

KZA Ann: Change in substantial holding

KZA Ann: Change in substantial holding

KZA Ann: Cleansing Notice

KZA Ann: Application for quotation of securities - KZA

KZA Ann: Change in substantial holding

KZA Ann: Change in substantial holding

KZA Ann: Notification of cessation of securities - KZA

KZA Ann: Interim data from MSKCC study

KZA Ann: GBM Agile Update

KZA Ann: Quarterly Activities/Appendix 4C Cash Flow Report

KZA Ann: Quarterly Activities/Appendix 4C Cash Flow Report

KZA Ann: Kazia launches new SAB

KZA Ann: Cleansing notice

KZA Ann: Application for quotation of securities - KZA

KZA Ann: FDA grants RPDD to paxaliaib for AT/RT

KZA Ann: Kazia progress update

KZA Ann: Ceasing to be a substantial holder

Register to track KZA and receive email alerts.

Similar Companies

CSL ...
CSL
CUV
IMM
IMU
MSB
OPT
PAR
PYC
RAC
TLX